Adding cabergoline to letrozole for ovulation in PCOS
Official title: Cabergoline and Letrozole Compared to Letrozole Alone for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome
Run by Bangladesh Medical University · NCT07255911 · Data updated 2026-11-12
This study will see if adding cabergoline to letrozole helps women with PCOS ovulate more often.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | Women only |
| Enrollment | 72 (estimated) |
| Sponsor | Bangladesh Medical University Academic / other |
| Locations | 1 site (Dhaka, Shahbag) |
| Status | Recruiting |
| Started | February 7, 2025 |
| Main results expected | January 6, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | December 16, 2025 |
| Trial ID | NCT07255911 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–35 with PCOS by Rotterdam criteria who have primary or secondary subfertility, meet BMI and lab limits, and are selected for ovulation induction are ideal candidates.
✕Probably not a fit
Women with other infertility causes (male factor, tubal or uterine disease), very high prolactin, uncontrolled medical conditions, extreme BMI, or those taking excluded medications are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled trial at Bangladesh Medical University comparing combined cabergoline plus letrozole to letrozole alone for ovulation induction in women with PCOS. Eligible participants (age 18–35, PCOS by Rotterdam criteria, seeking fertility) are randomized by permuted blocks with allocation concealed in opaque sealed envelopes. The intervention arm receives cabergoline 0.5 mg on cycle days 2 and 9 plus letrozole 5 mg daily for five days starting cycle day 2, while the comparator receives letrozole alone; transvaginal ultrasound monitoring is performed across up to three cycles to track ovarian response. Outcomes include ovulation rate and related fertility measures, with standard exclusions for other infertility causes, high prolactin, extreme BMI, uncontrolled medical disease, and certain concomitant medications.
Why it matters
Potential benefit: If successful, the combination could increase ovulation rates and improve chances of conception for women with PCOS seeking fertility.
How similar studies have gone: Letrozole is established for ovulation induction and dopamine agonists are used for hyperprolactinemia, but combining cabergoline with letrozole for ovulation induction is not well established and supporting evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. PCOS patients diagnosed according to Rotterdam criteria. 2. Age: 18-35 years. 3. Primary or secondary subfertility. 4. Selected for ovulation induction. Exclusion Criteria: 1. Women suffered from PCOS like symptom ex. Late onset congenital adrenal hyperplasia, Cushing syndrome. 2. Serum prolactin (more than 50 ng/ml) (Kyritsi et al., 2018). 3. Male factor infertility. 4. Women with other infertility factors (endometriosis, PID,uterine \& tubal causes of infertility). 5. Uncontrolled Medical disease (DM, HTN, kidney disease, liver disease). 6. History of hypersensitivity to cabergoline \& letrozole. 7. Thyroid dysfunction ( serum TSH ≥5mIU/L) 8. BMI:\< 18.5 kg/m2 and ≥30 kg/m2. 9. Patients on metformin therapy. 10. Patient on antiemetic like Domperidone metoclopramide, antipsychotic drug like haloperidol and risperidone, tricyclic antidepressant like amitriptyline, clomipramine, antihypertensive like verapamil, methyldopa, reserpine.
Where it's running
-
Bangladesh Medical University
Dhaka, Shahbag, Bangladesh Recruiting
Study contacts
- Study coordinator: Mst.Sumyara Khatun, MS
- Email: sumirmc09@gmail.com
- Phone: +8801746046581
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
PCOS and Brain Health
This study tests how PCOS may affect brain blood flow, brain structure, and thinking skills in reproductive-age people with and without PCOS.
-
Investigating cardiovascular markers in women with PCOS during glucose testing
This study is testing how glucose testing affects heart health markers in women with PCOS and whether different treatments can improve those markers over six months.
-
PIMS versus PGT-A for embryo selection in women with PCOS
This test will see if selecting embryos with Pre-implantation Methylation Screening (PIMS) instead of PGT-A plus standard morphology leads to higher cumulative live birth rates and lower early pregnancy loss for women with PCOS undergoing IVF/ICSI.
-
Comparing adipokine levels in women with and without PCOS
This study is trying to see how levels of certain fat-related proteins differ in women with polycystic ovary syndrome (PCOS), both with and without insulin resistance, compared to women without PCOS.
-
Using liraglutide to improve fertility in obese women with PCOS
This study is testing if giving liraglutide, along with metformin, can help obese women with PCOS improve their chances of having a baby through IVF by losing weight and getting healthier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.